BBC icon

Virtus LifeSci Biotech Clinical Trials ETF

18 hedge funds and large institutions have $7.19M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 3 closing their positions.

Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
6
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Goldman Sachs
1
Goldman Sachs
New York
$2.79M 100,000
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$2.38M 85,298 -9,433 -10%
LPL Financial
3
LPL Financial
California
$1.06M 37,921 -8,099 -18%
FTUS
4
Flow Traders U.S.
New York
$530K 18,961 -7,525 -28%
Morgan Stanley
5
Morgan Stanley
New York
$188K 6,722 -799 -11%
Osaic Holdings
6
Osaic Holdings
Arizona
$72K 2,549 -56 -2%
UBS Group
7
UBS Group
Switzerland
$47K 1,684 -622 -27%
US Bancorp
8
US Bancorp
Minnesota
$28K 1,000
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Quebec, Canada
$23.4K 838
CAPTRUST Financial Advisors
10
CAPTRUST Financial Advisors
North Carolina
$18K 655
MW
11
Milestone Wealth
New York
$17K 433
GRP
12
Global Retirement Partners
California
$8K 408 +408 New
Wells Fargo
13
Wells Fargo
California
$6K 225
MCC
14
Money Concepts Capital
Florida
$6K 220 +220 New
ODG
15
O'Dell Group
Ohio
$3K 117
ARMC
16
American Research & Management Company
Massachusetts
$3K 100 +100 New
BAM
17
Baldrige Asset Management
Pennsylvania
$1K 23
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
-9,830 Closed
RG
19
Retirement Group
California
-250 Closed
SWM
20
Spire Wealth Management
Virginia
-200 Closed
CFGS
21
Concourse Financial Group Securities
Alabama
MA
22
Montag & Associates
Georgia
$0 3